Nanotechnology has extensive application as nanomedicine in the medical field.Some nanoparticles have pos-sible applications in novel diagnostic instruments,imagery and methodologies,targeted medicinal products,pharmaceutical products,biomedical implants,and tissue engineering.Today treatments of high toxicity can be administered with improved safety using nanotechnology,such as chemotherapeutic cancer drugs.Further,wear-able gadgets can detect crucial changes in vital signs,cancer cell conditions,and infections that are genuinely happening in the body.We anticipate these technologies to provide doctors with considerably much better direct access to critical data on the reasons for changes in the signs of life or illness because of the technological presence at the source of the problem.Biomedicine can be utilised for therapies with predictive analytics and artificial intelligence.For carrying out this study,relevant papers on Nanotechnology in the medical field from Scopus,Google scholar,ResearchGate,and other research platforms are identified and studied.The study discusses dif-ferent types of Nanoparticles used in the medical field.This paper discusses nanotechnology applications in the medical field.The class,features,and characteristics of Nanotechnology for medicine are also briefed.Scientists,governments,civil society organisations,and the general public will need to collaborate across sectors to assess the significance of nanotechnology and guide its advancement in various fields.The current research includes sev-eral possible Nanotechnology uses in the medical field.As a result,the study provides a brief and well-organised report on nanotechnology that should be valuable to researchers,engineers,and scientists for future research projects.

This paper introduced the implementing process, characteristics and effects of the web research learning of physiology. Research learning based on Web promoted reform of physiology teaching, enhanced ability of self-study, integration and innovative of students

PURPOSE: The Asia-Pacific Burden of Respiratory Diseases (APBORD) study is a cross-sectional, observational one which has used a standard protocol to examine the disease and economic burden of allergic rhinitis (AR), asthma, chronic obstructive pulmonary disorder (COPD), and rhinosinusitis across the Asia-Pacific region. Here, we report on symptoms, healthcare resource use, work impairment, and associated costs in Korea. METHODS: Consecutive participants aged ≥18 years with a primary diagnosis of asthma, AR, COPD, or rhinosinusitis were enrolled. Participants and their treating physician completed a survey detailing respiratory symptoms, healthcare resource use, and work productivity and activity impairment. Costs included direct medical cost and indirect cost associated with lost work productivity. RESULTS: The study enrolled 999 patients. Patients were often diagnosed with multiple respiratory disorders (42.8%), with asthma/AR and AR/rhinosinusitis the most frequently diagnosed combinations. Cough or coughing up phlegm was the primary reason for the medical visit in patients with a primary diagnosis of asthma and COPD, whereas nasal symptoms (watery runny nose, blocked nose, and congestion) were the main reasons in those with AR and rhinosinusitis. The mean annual cost for patients with a respiratory disease was US$8,853 (SD 11,245) per patient. Lost productivity due to presenteeism was the biggest contributor to costs. CONCLUSIONS: Respiratory disease has a significant impact on disease burden in Korea. Treatment strategies for preventing lost work productivity could greatly reduce the economic burden of respiratory disease.
Asthma* ; Cost of Illness ; Cough ; Delivery of Health Care ; Diagnosis ; Efficiency ; Health Care Costs ; Humans ; Korea* ; Nose ; Observational Study* ; Presenteeism ; Pulmonary Disease, Chronic Obstructive* ; Respiratory Tract Diseases ; Rhinitis, Allergic*

Introduction: Myopia is an emerging vision problem that causes public health and economic burden worldwide and associated with increased risk to many ocular conditions leading to blindness. This study aimed to evaluate patterns of visual field defects in Malay population with myopia. Methods: A retrospective study was conducted between January 2018 until June 2018 at MSU Eye Centre and data was obtained from patient records of Malay subjects with myopia and free from any ocular and systemic diseases. The spherical equivalent (SE) of the refractive errors and the global indices (mean deviation, MD and pattern of standard deviation, PSD) of OCULUS Twinfield® 2 with SPARK strategy were recorded for this study. Results: A total of 90 eyes with the mean age of 29.16 (SD: 10.27) years old and SE (M= -2.92 D, SD:2.94 D) were selected. The mean of MD was -1.71 dB (SD 3.95 dB) and PSD was 1.81 dB (SD:1.82 dB) respectively. Significant differences was found in MD (p=0.012) and PSD (p=0.01) between the three groups. The localised field defect was observed in the moderate to high myopic eyes in all quadrants (p=0.01) for PP2, and also more prevalent pattern found in all quadrants for PP1 except at superior quadrant (p=0.08). Conclusions: There is a localised visual field defect found in a higher degree of myopia particularly at temporal, nasal and inferior quadrants. Thus, the visual field test is recommended as a routine procedure in moderate to high myopic eyes and need to be interpreted with caution.